MEDO receives FDA approval to Revolutionize Thyroid Ultrasound. ...Middle East

PR Newswire - News
MEDO receives FDA approval to Revolutionize Thyroid Ultrasound.
EDMONTON, AB, May 6, 2021 /PRNewswire/ - Medo, an artificial intelligence technology start-up company headquartered in Singapore and Canada, is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration for the world's first tool using Artificial...

Hence then, the article about medo receives fda approval to revolutionize thyroid ultrasound was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MEDO receives FDA approval to Revolutionize Thyroid Ultrasound. )

Apple Storegoogle play

Last updated :

Also on site :